PharmaCyte Biotech Inc (PMCB)

[Triple9]

The shorts on $PMCB really have no clue how big pharma operates,

We are waiting on IND for CiaB and ifosfamide for pancreatic cancer. That's just one biologic. CiaB with a single proven chemotherapy drug for a specific type of cancer.

But CiaB can be used with any chemo drugs on any solid tumors. The potential is limitless.

Imagine you are a big pharma with dozens of chemotherapy drugs that are going off or have gone off exclusivity. The billions spent on R&D for those drugs was largely recouped, but now you stand to regain exclusivity by working with $PMCB.

So, do you just let your chemo drug go generic or do you turn it into a new, exclusive biologic by putting it inside CiaB?

Janssen has nearly 30 chemotherapy drugs.

http://www.janssen.com/products/Oncology

Chemotherapy is like carpet bombing a person's body. CiaB turns that very same medicine into a laser-guided missle.